Get the Stockscreener App
48.37
1.09%
0.52
After Hours:
48.37
Alexandria Real Estate Equities Inc stock is traded at $48.37, with a volume of 1.39M.
It is up +1.09% in the last 24 hours and up +3.69% over the past month.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.
See More
Previous Close:
$47.85
Open:
$47.94
24h Volume:
1.39M
Relative Volume:
0.59
Market Cap:
$8.43B
Revenue:
$2.94B
Net Income/Loss:
$-865.55M
P/E Ratio:
-7.7102
EPS:
-6.2735
Net Cash Flow:
$1.40B
1W Performance:
+7.56%
1M Performance:
+3.69%
6M Performance:
-4.95%
1Y Performance:
-29.50%
1-Day Range:
$47.67
$48.52
1-Week Range:
$45.15
$48.52
52-Week Range:
$39.41
$88.24
Alexandria Real Estate Equities Inc Stock (ARE) Company Profile
Name
Alexandria Real Estate Equities Inc
Sector
Industry
Phone
(626) 578-0777
Address
26 NORTH EUCLID AVENUE, PASADENA, CA
Compare ARE vs BXP, VNO, CUZ, KRC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARE
Alexandria Real Estate Equities Inc
|
48.37 | 8.34B | 2.94B | -865.55M | 1.40B | -6.2735 |
BXP
Bxp Inc
|
60.29 | 9.59B | 3.48B | 384.00M | 686.12M | 1.7389 |
VNO
Vornado Realty Trust
|
31.98 | 5.95B | 1.81B | 815.35M | 1.01B | 3.6417 |
CUZ
Cousins Properties Inc
|
26.50 | 4.35B | 1.01B | -4.51M | 125.43M | -0.0334 |
KRC
Kilroy Realty Corp
|
33.97 | 3.97B | 1.11B | 243.55M | 580.09M | 1.8259 |
Alexandria Real Estate Equities Inc Stock (ARE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-25-26 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Feb-03-26 | Initiated | Goldman | Neutral |
| Jan-09-26 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-13-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Oct-29-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-06-25 | Initiated | Jefferies | Hold |
| Oct-01-25 | Downgrade | BNP Paribas Exane | Neutral → Underperform |
| Oct-01-25 | Initiated | Cantor Fitzgerald | Neutral |
| Sep-23-25 | Initiated | BMO Capital Markets | Outperform |
| Sep-15-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-17-25 | Initiated | Jefferies | Hold |
| Nov-27-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-15-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-25-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-13-24 | Downgrade | Citigroup | Buy → Neutral |
| Aug-02-24 | Downgrade | Jefferies | Buy → Hold |
| Jul-29-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-25-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-24-24 | Downgrade | Wedbush | Outperform → Neutral |
| Jan-30-24 | Initiated | Deutsche Bank | Buy |
| Oct-11-23 | Initiated | Exane BNP Paribas | Neutral |
| Oct-03-23 | Initiated | Wedbush | Outperform |
| Jul-20-23 | Initiated | Jefferies | Buy |
| Jun-23-22 | Initiated | Credit Suisse | Neutral |
| Jul-14-21 | Resumed | Mizuho | Buy |
| Jan-07-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-02-20 | Initiated | Berenberg | Buy |
| Jun-08-20 | Resumed | JMP Securities | Mkt Outperform |
| Feb-04-20 | Resumed | Mizuho | Buy |
| Dec-18-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-18-19 | Downgrade | RBC Capital Mkts | Top Pick → Outperform |
| Dec-19-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Dec-14-18 | Upgrade | RBC Capital Mkts | Outperform → Top Pick |
| Dec-03-18 | Upgrade | Citigroup | Neutral → Buy |
| Dec-04-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Aug-04-16 | Reiterated | Mizuho | Buy |
| Aug-04-16 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-08-16 | Reiterated | Mizuho | Buy |
| Oct-20-15 | Reiterated | Barclays | Overweight |
| Oct-19-15 | Reiterated | Mizuho | Buy |
| Oct-13-15 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-24-15 | Reiterated | Barclays | Overweight |
| Feb-05-15 | Reiterated | RBC Capital Mkts | Outperform |
| Feb-04-15 | Reiterated | Mizuho | Neutral |
| Jan-13-15 | Reiterated | Robert W. Baird | Neutral |
| Jan-09-15 | Downgrade | UBS | Buy → Neutral |
View All
Alexandria Real Estate Equities Inc Stock (ARE) Latest News
A Look At Alexandria Real Estate Equities (ARE) Valuation As Shares Show Short Term Strength - simplywall.st
Are Wall Street Analysts Bullish on Alexandria Real Estate Stock? - Yahoo Finance
Handelsbanken Fonder AB Has $2.11 Million Stake in Alexandria Real Estate Equities, Inc. $ARE - MarketBeat
Alexandria Real Estate Equities Inc. stock underperforms Wednesday when compared to competitors - MSN
Alexandria Real Estate stock faces biotech headwinds amid restructuring By Investing.com - Investing.com Nigeria
Alexandria Real Estate Equities stock (US0152711022): Focus on life science campuses after recent ea - AD HOC NEWS
TD Private Client Wealth LLC Decreases Holdings in Alexandria Real Estate Equities, Inc. $ARE - MarketBeat
Alexandria Real Estate stock faces biotech headwinds amid restructuring - Investing.com
Real estate stocks outperform broader markets (XLRE:NYSEARCA) - Seeking Alpha
Diamond Hill Capital Management Inc. Takes $8.45 Million Position in Alexandria Real Estate Equities, Inc. $ARE - MarketBeat
Kawa Capital Management, Inc's Alexandria Real Estate Equities Inc(ARE) Holding History - GuruFocus
Alexandria Real Estate Equities Inc. stock outperforms competitors on strong trading day - MarketWatch
(ARE) and the Role of Price-Sensitive Allocations - Stock Traders Daily
symbol__ Stock Quote Price and Forecast - CNN
Top Alexandria Real Estate Equities (ARE) Competitors 2026 - MarketBeat
Alexandria Real Estate Equities stock (US0152711022): Earnings outlook and life science demand in fo - AD HOC NEWS
Zacks Research Issues Positive Forecast for ARE Earnings - MarketBeat
Alexandria Real Estate Equities stock (US0152711022): solid Q1 2026 results and steady life?science - AD HOC NEWS
Goldman Sachs Maintains Alexandria Real Estate Equities Inc(ARE.US) With Hold Rating, Cuts Target Price to $52 - 富途牛牛
Zacks Research Has Bullish Forecast for ARE FY2026 Earnings - MarketBeat
Truist Financial Corp Cuts Stake in Alexandria Real Estate Equities, Inc. $ARE - MarketBeat
Alexandria Real Estate Equities stock (US0152711022): Latest catalyst and business snapshot - AD HOC NEWS
Alexandria Real Estate Equities, Inc. Common Stock (NY: ARE - The Chronicle-Journal
Alexandria Real Estate Equities stock (US0152711022): Dividend hike and guidance update put focus on - AD HOC NEWS
Alexandria Real Estate Equities Inc. stock outperforms competitors despite losses on the day - MarketWatch
REITs Are Winning Again: Here’s Why - Seeking Alpha
Goldman Sachs Adjusts PT on Alexandria Real Estate Equities to $52 From $60, Maintains Neutral Rating - marketscreener.com
Alexandria Real Estate Equities Inc (ARE) Shares Surge 3.8% -- W - GuruFocus
Alexandria Real Estate Equities Inc (ARE) Shares Surge 3.8% -- What GF Score of 59 Tells Investors - GuruFocus
Alexandria Real Estate Equities stock (US0152711022): Life science REIT updates investors after rece - AD HOC NEWS
Alexandria Real Estate Equities stock (US0152711022): analysts weigh upside as life science REIT sta - AD HOC NEWS
A Look At Alexandria Real Estate Equities (ARE) Valuation After Earnings Beat And Sector Downgrades - simplywall.st
What Alexandria Real Estate Equities (ARE)'s Mixed Q1 Beat Amid Sector Headwinds Means For Shareholders - simplywall.st
Alexandria Real Estate Equities Inc. stock underperforms Friday when compared to competitors - MarketWatch
Alexandria Real Estate Equities stock (US0152711022): annual meeting keeps focus on REIT - AD HOC NEWS
Alexandria Real Estate Equities stock (US0152711022): earnings outlook and life science focus draw a - AD HOC NEWS
Alexandria Real Estate Equities (ARE) Stock Price, News & Analysis $ARE - MarketBeat
Alexandria Equities Stockholders Approve Directors and Key Proposals - TipRanks
Alexandria Real Estate Equities Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Alexandria Real Estate Equities shareholders elect directors and approve key proposals - Investing.com
Alexandria Real Estate Equities stock (US0108601063): Insider buys signal confidence amid Q1 results - AD HOC NEWS
Baird maintains Alexandria Real Estate Equities (ARE) outperform recommendation - MSN
News | REIT to enter senior housing sector with deals for three DC-area properties - CoStar
Is S&P 500 Momentum Reviving Alexandria Real Estate Shares? - Kalkine Media
Alexandria Real Estate Equities stock (US0152711021): Analyst targets climb amid governance pressure - AD HOC NEWS
Is Alexandria Real Estate Equities (ARE) Pricing Reflect A Potential Recovery After Multi‑Year Slide? - simplywall.st
Alexandria Real Estate Equities stock (US0152711022): Analyst targets surge 32% amid life sciences d - AD HOC NEWS
Alexandria Real Estate Equities, Inc. Stock 12‑Month Price Target Cut to $51.25, Implies 10% Upside - TradingView
Alexandria Real Estate Equities stock (US0108601063): Insider Buying and Recent Analyst Updates - AD HOC NEWS
Alexandria Dividend Cut Tests Life Science REIT Valuation And Income Appeal - Yahoo Finance
Can S&P 500 Trends Lift Alexandria Real Estate Momentum? - Kalkine Media
Alexandria Real Estate Equities Inc Stock (ARE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):